Detalhe da pesquisa
1.
Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model.
Cancer Res
; 62(17): 4996-5000, 2002 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-12208752
2.
Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer.
J Clin Oncol
; 22(11): 2108-21, 2004 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15169797
3.
Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies.
J Clin Oncol
; 20(22): 4420-7, 2002 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-12431963
4.
A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies.
Clin Cancer Res
; 8(8): 2505-11, 2002 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-12171876
5.
Assays for proteasome inhibition.
Methods Mol Med
; 85: 163-72, 2003.
Artigo
Inglês
| MEDLINE | ID: mdl-12710207
6.
Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90.
Proc Natl Acad Sci U S A
; 103(46): 17408-13, 2006 Nov 14.
Artigo
Inglês
| MEDLINE | ID: mdl-17090671